Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISRCTN14767962Phase 4Completed
Phase 4, randomised trial in bronchopulmonary diseases comparing Fluticasone propionate, Fluticasone propionate + salmeterol and Placebo (3 arms). Primary endpoint: Change in percent predicted FEV1. Started May 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ISRCTN14767962.